Influence of matrix metalloproteinase 9 variant rs17576 on ischemic stroke risk and severity in acute coronary

Neda M Bogari1, Hind Mansour Naffadi1, Ahmad O Babalghith1

  • 1Department of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.

Abstract

Insights

The MMP-9 rs17576 polymorphism

Area of Science:

  • Cardiovascular Research
  • Neurology
  • Genetics

Background:

  • Ischemic injury underlies both ischemic stroke (IS) and acute coronary syndrome (ACS).
  • Matrix metalloproteinase 9 (MMP-9) plays a role in IS pathogenesis.
  • The MMP-9 gene's rs17576 single nucleotide polymorphism (SNP) is investigated.

Purpose of the Study:

  • To assess the association of the MMP-9 rs17576 SNP with IS risk in Saudi Arab ACS patients.
  • To evaluate the link between the MMP-9 rs17576 SNP and ACS risk in individuals without IS.

Main Methods:

  • A case-control study included 200 IS patients, 520 ACS patients (no IS), and 500 controls.
  • Genotyping was performed to detect the MMP-9 rs17576 polymorphism.

Main Results:

  • No significant difference in MMP-9 rs17576 genotype/allele frequencies between IS and ACS (no IS) groups.
  • The AA genotype was significantly associated with IS risk compared to controls (OR=1.84).
  • The AA genotype was also significant for ACS (no IS) risk versus controls (OR=1.46).

Conclusions:

  • The MMP-9 rs17576 polymorphism showed no association between IS and ACS (no IS) groups.
  • A significant association was found between the mutant AA genotype and both IS and ACS (no IS) groups compared to controls.
  • rs17576 genotypes were not linked to increased mortality or early neurological deterioration.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...